Haleon’s pilot run of the screener analyzed 1,500 pieces of creative for the Panadol pain relief brand across nine markets.

The approval comes just in time for the current RSV season in the US, which typically runs from October to April. Abrysvo’s main competitor is GSK’s Arexvy, which is approved in the same indication.

In its lawsuit, GSK has alleged the use of its technology without proper licenses. GSK is suing Moderna in two lawsuits regarding its mRNA vaccines: Spikevax for Covid-19 and mResvia for RSV. The ...

Copyright 2024 The Associated Press. All Rights Reserved. In this photo provided by Egypt’s presidency media office, Egyptian President Abdel-Fattah el-Sissi, right ...

Gen. Abbas Kamel, a longtime confidant of Egypt’s president, oversaw the country’s most important international relationships and helped maintain the president’s authoritarian grip.

The Grand Egyptian Museum will open 12 halls with exhibits about ancient Egypt in its main galleries starting this week in a trial run ahead of the still-unannounced official opening, officials ...

The update on the GSK-partnered prospect sent Wave’s share price up 63% to almost $14 despite coinciding with news that Takeda has axed a deal for another asset. The ongoing phase 1b/2a study is ...

Copyright 2024 The Associated Press. All Rights Reserved. The Grand Egyptian Museum will partially open its main galleries on Wednesday, including 12 halls that ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...

GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...